Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
IRADIMED
NasdaqGM:IRMD Community
1
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Create a narrative
IRADIMED
Popular
Undervalued
Overvalued
IRADIMED
WA
Analyst Price Target
Consensus Narrative from 2 Analysts
Expansion And New MRI-Compatible Pump Set To Strengthen Future Earnings Stability
Key Takeaways Strategic moves to expand production capacity and modify sales plans aim to stabilize revenue and capitalize on new product demand. Robust cash flow from improved working capital management supports future growth initiatives and earnings stability.
View narrative
US$65.00
FV
13.5% undervalued
intrinsic discount
14.65%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
Your Valuation for
IRMD
IRADIMED
Your Fair Value
US$
Current Price
US$56.24
21.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
131m
2015
2018
2021
2024
2025
2027
2030
Revenue US$131.1m
Earnings US$34.4m
Advanced
Set as Fair Value